Cumulative incidences of various CVDs by treatment group, with death from any cause other than CVD as competing risk. (A) Cumulative incidence of all CVDs combined by treatment group with death from any cause as competing risk. Med RT indicates mediastinal RT; CT, chemotherapy; anthra, anthracyclines; MI, myocardial infarction; AP, angina pectoris; and CHF, congestive heart failure. †Thirteen patients were excluded from this analysis because they developed MI, AP, or CHF before or within 5 years after HL diagnosis. (B) Cumulative incidence of CHF and cardiomyopathy combined by treatment group with death from any cause as competing risk. Med RT, mediastinal RT; CT, chemotherapy; anthra, anthracyclines; CHF, congestive heart failure. *One patient was excluded from this analysis because CHF developed before or within 5 years after HL diagnosis. (C) Cumulative incidence of valvular disorders by treatment group, with death from any cause as competing risk. Med RT indicates mediastinal RT; CT, chemotherapy; anthra, anthracyclines. #Four patients were excluded from this analysis because they developed valvular disorders before or within 5 years after HL diagnosis.